Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Lisata Therapeutics (LSTA) EBITDA Margin (2016 - 2025)

Historic EBITDA Margin for Lisata Therapeutics (LSTA) over the last 11 years, with Q2 2025 value amounting to 6954.29%.

  • Lisata Therapeutics' EBITDA Margin changed N/A to 6954.29% in Q2 2025 from the same period last year, while for Sep 2025 it was 1876.45%, marking a year-over-year change of. This contributed to the annual value of 2240.9% for FY2024, which is N/A changed from last year.
  • According to the latest figures from Q2 2025, Lisata Therapeutics' EBITDA Margin is 6954.29%.
  • In the past 5 years, Lisata Therapeutics' EBITDA Margin ranged from a high of 494.9% in Q4 2024 and a low of 6954.29% during Q2 2025